Mussel-inspired bioactive surface coating composition generating silica nanoparticles
US-9801972-B2 · Oct 31, 2017 · US
Antibodies that specifically bind to DRG11-responsive (dragon) proteins
US9637539B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9637539-B2 |
| Application number | US-201414307264-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 17, 2014 |
| Priority date | Apr 18, 2002 |
| Publication date | May 2, 2017 |
| Grant date | May 2, 2017 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
This invention features antibodies that specifically bind to a human Dragon family protein.
First claim
Opening claim text (preview).
What is claimed is: 1. A composition consisting essentially of an antibody that specifically binds to an amino acid sequence contained within the amino acid sequence of SEQ ID NO:10. 2. The antibody of claim 1 , wherein the antibody is monoclonal. 3. The antibody of claim 1 , wherein the antibody is polyclonal. 4. The antibody of claim 1 , wherein the antibody binds to the protein with a dissociation constant of less th…
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9637539B2 cover?
- This invention features antibodies that specifically bind to a human Dragon family protein.
- Who is the assignee on this patent?
- Massachusetts Gen Hospital
- What technology area does this patent fall under?
- Primary CPC classification C07K14/43509. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue May 02 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).